- * Healthy subject, male or female, 6 through \< 48 months of age at the time of enrollment, who has never previously received an influenza vaccine
- * Individual who has a parent or guardian that can give written informed consent after understanding the nature of the study and are available for follow-up
Influenza
Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old
NCT02035696 | PHASE 1 | INTERVENTIONAL
To evaluate the safety and immunogenicity of four influenza vaccines in children 6 months to \< 48 months of age
Trial Information
If interested, contact clinicaltrials@cslbehring.com for more information
CSL Behring respects your privacy. For an explanation of how CSL Behring will use the information you are submitting, please view our Privacy Policy
Site
Phoenix,Arizona,United States
Site
Tucson,Arizona,United States
Site
Little Rock,Arkansas,United States
Site
Long Beach,California,United States
Site
Ontario,California,United States
Site
San Diego,California,United States
Site
West Covina,California,United States
Site
Thornton,Colorado,United States
Site
Miami Beach,Florida,United States
Site
Miami,Florida,United States
Site
Gainesville,Georgia,United States
Site
Omaha,Nebraska,United States
Site
Omaha,Nebraska,United States
Site
Omaha,Nebraska,United States
Site
Omaha,Nebraska,United States
Site
Youngstown,Ohio,United States
Site
Charleston,South Carolina,United States
Site
Houston,Texas,United States
Site
Saint George,Utah,United States
Site
Salt Lake City,Utah,United States
Site
Spokane,Washington,United States
Site
Kuopio,Finland
Site
Tampere,Finland
Site
Manila,Philippines
Site
Muntinlupa,Philippines
Site
Bangkok,Thailand
Site
Bangkok,Thailand
Study Eligibility Criteria
Additional Studies
Additional studies can be found at ClinicalTrials.gov